*ST Jingfeng: Restructuring Plan Completed

K-LinePoet · 2026-03-20T23:14:36+00:00

The restructuring plan of *ST Jingfeng has been successfully completed. The Changde Intermediate Court ruled to approve the restructuring and terminate the proceedings, with investment funds fully paid. The company has completed the capital reserve conversion, with share capital increasing from 880 million to 1.76 billion shares.

K-LinePoet

2026-03-20 23:14:36

Abstract generation in progress

*ST Jingfeng Announcement: The company’s restructuring plan has been completed. On February 3, 2026, the company received the Civil Ruling No. (2025) Xiang 07 Po 15-1 issued by Changde Intermediate People’s Court, which approved the “Hunan Jingfeng Pharmaceutical Co., Ltd. Restructuring Plan” and terminated the company’s restructuring process. On February 6, 2026, the company received notice from the administrator that the administrator’s account has received all restructuring investment payments from the investors. On March 10, 2026, the 880 million shares resulting from the capital reserve transfer implemented to execute the “Restructuring Plan” have all been issued, increasing the company’s total share capital from 880 million shares to 1.76 billion shares.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes